文献速递心血管CT

基于心脏计算机断层扫描的评分对二尖瓣环钙化严重程度分级并预测瓣膜栓塞

A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-05-13

本研究基于多中心回顾性心脏CT与临床结局数据,建立了一套二尖瓣环钙化(MAC)的CT评分系统(总分最高10分,轻度≤3分、中度4~6分、重度≥7分),用于对接受经导管二尖瓣置换的MAC患者进行严重程度分级,并评估其与瓣膜移位/栓塞的关联;结果显示MAC评分≤6分是瓣膜栓塞/移位的独立预测因素(OR 5.86,95%CI 1.00~34.26,P=0.049)。

要点

  • MAC评分由钙化平均厚度、瓣环周径受累度数、纤维三角钙化及瓣叶钙化四项构成,总分最高10分。
  • 评分≤6分者栓塞/移位率60%,显著高于评分≥7分者的9.7%(P<0.001)。
  • 多变量分析中MAC评分≤6分为瓣膜栓塞/移位的独立预测因素(OR 5.86,95%CI 1.00~34.26,P=0.049)。

关键影像表现/征象

  • MAC评分基于钙化平均厚度(mm)、瓣环周径受累度数、一个或两个纤维三角钙化、一个或两个瓣叶钙化四项特征。
  • 各特征按严重程度赋分,总分最高10分,据此分为轻度≤3分、中度4~6分、重度≥7分。
  • 平均MAC评分为7.7±1.4。

诊断标准与关键数值

  • MAC评分≤6分者栓塞/移位率60%,MAC评分≥7分者9.7%(P<0.001)。
  • MAC评分7分者瓣膜栓塞/移位率12.5%,评分≥8分者8.7%,评分≥9分者为0(P=0.023)。
  • 多变量分析中MAC评分≤6分为瓣膜栓塞/移位的独立预测因素(OR 5.86,95%CI 1.00~34.26,P=0.049)。

临床应用与阅片要点

  • 对拟行ViMAC的患者,可依据心脏CT测量钙化平均厚度、瓣环周径受累度数、纤维三角及瓣叶钙化进行MAC评分。
  • 评分≤6分提示瓣膜栓塞/移位风险较高,评分≥7分者风险较低,评分≥9分者本队列中未见栓塞/移位。

局限性

  • 本文为多中心回顾性研究。
  • TMVR in MAC注册研究中87例有合格基线心脏CT,15例经心房途径治疗者未纳入,最终队列72例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aims to establish a computed tomography (CT)-based scoring system for grading mitral annular calcification (MAC) severity and potentially aid in predicting valve embolization during transcatheter mitral valve (MV) replacement using balloon-expandable aortic transcatheter heart valves.

BACKGROUND: Transcatheter MV replacement is emerging as an alternative treatment for patients with severe MAC who are not surgical candidates. Although cardiac CT is the imaging modality of choice in the evaluation of candidates for valve-in-MAC (ViMAC), a standardized grading system to quantify MAC severity has not been established.

METHODS: We performed a multicenter retrospective review of cardiac CT and clinical outcomes of patients undergoing ViMAC. A CT-based MAC score was created using the following features: average calcium thickness (mm), degrees of annulus circumference involved, calcification at one or both fibrous trigones, and calcification of one or both leaflets. Features were assigned points according to severity (total maximum score = 10) and severity grade was assigned based on total points (mild ≤3, moderate 4 to 6, and severe ≥7 points). The association between MAC score and device migration/embolization was evaluated.

RESULTS: Of 117 patients in the TMVR in MAC registry, 87 had baseline cardiac CT of adequate quality. Of these, 15 were treated with transatrial access and were not included. The total cohort included 72 (trans-septal = 37, transapical = 35). Mean patient age was 74 ± 12 years, 66.7% were female, and the mean Society of Thoracic Surgery risk score was 15.4 ± 10.5%. The mean MAC score was 7.7 ± 1.4. Embolization/migration rates were lower in higher scores: Patients with a MAC score of 7 had valve embolization/migration rate of 12.5%, MAC score ≥8 had a rate of 8.7%, and a MAC score of ≥9 had zero (p = 0.023). Patients with a MAC score of ≤6 had 60% embolization/migration rate versus 9.7% in patients with a MAC score ≥7 (p < 0.001). In multivariable analysis, a MAC score ≤6 was in independent predictor of valve embolization/migration (odds ratio [OR]: 5.86 [95% CI: 1.00 to 34.26]; p = 0.049).

CONCLUSIONS: This cardiac CT-based score provides a systematic method to grade MAC severity which may assist in predicting valve embolization/migration during trans-septal or transapical ViMAC procedures.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Guerrero M, Wang DD, Pursnani A, et al. A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. JACC Cardiovasc Imaging. 2020. PMID: 32417332. doi:10.1016/j.jcmg.2020.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。